Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb 26;7(2):24.
doi: 10.3390/geriatrics7020024.

The Multifaceted Role of Neuroprotective Plants in Alzheimer's Disease Treatment

Affiliations
Review

The Multifaceted Role of Neuroprotective Plants in Alzheimer's Disease Treatment

Tarek Zieneldien et al. Geriatrics (Basel). .

Abstract

Alzheimer's disease (AD) is an age-related, progressive neurodegenerative disorder characterized by impaired cognition, memory loss, and altered personality. Many of the available pharmaceutical treatments do not alter the onset of disease progression. Recently, alternatives to developed drug candidates have been explored including medicinal plants and herbal treatments for the treatment of AD. This article examines the role of herbal plant extracts and the neuroprotective effects as alternative modes of intervention for AD progression. These extracts contain key metabolites that culminate alterations in AD progression. The traditional plant extracts explored in this article induce a variety of beneficial properties, including antioxidants, anti-inflammatory, and enhanced cognition, while also inducing activity on AD drug targets such as Aβ degradation. While these neuroprotective aspects for AD are relatively recent, there is great potential in the drug discovery aspect of these plant extracts for future use in AD treatment.

Keywords: Alzheimer’s disease; amyloid beta; anti-inflammatory; antioxidant; herbal medicine; natural products; oxidative stress; tau protein.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

Cited by

References

    1. Alzheimer’s Association 2021 Alzheimer’s disease facts and figures. Alzheimer’s Dement. 2021;17:327–406. doi: 10.1002/alz.12328. - DOI - PubMed
    1. Corey-Bloom J. The ABC of Alzheimer’s disease: Cognitive changes and their management in Alzheimer’s disease and related dementias. Int. Psychogeriatr. 2002;14((Suppl. 1)):51–75. doi: 10.1017/S1041610203008664. - DOI - PubMed
    1. Bekris L.M., Yu C.E., Bird T.D., Tsuang D.W. Genetics of Alzheimer disease. J. Geriatr. Psychiatry Neurol. 2010;23:213–227. doi: 10.1177/0891988710383571. - DOI - PMC - PubMed
    1. Huang Y. Roles of apolipoprotein E4 (ApoE4) in the pathogenesis of Alzheimer’s disease: Lessons from ApoE mouse models. Biochem. Soc. Trans. 2011;39:924–932. doi: 10.1042/BST0390924. - DOI - PubMed
    1. Guerreiro R., Bras J. The age factor in Alzheimer’s disease. Genome Med. 2015;7:106. doi: 10.1186/s13073-015-0232-5. - DOI - PMC - PubMed

LinkOut - more resources